Association of Galectin-3 and Soluble ST2, and Their Changes, with Echocardiographic Parameters and Development of Heart Failure after ST-Segment Elevation Myocardial Infarction.
Krzysztof OzierańskiAgnieszka Kapłon-CieślickaKrzysztof OzierańskiMonika BudnikAnna WancerzPiotr SypieńMichał PellerPaweł BalsamGrzegorz OpolskiKrzysztof J FilipiakPublished in: Disease markers (2019)
Baseline, but not one-year, changes of Gal-3 and sST2 concentrations may be useful for risk stratification after STEMI. However, only Gal-3 was the independent predictor of HF development at one-year observation. This trial is registered with NCT03735719.
Keyphrases
- st segment elevation myocardial infarction
- percutaneous coronary intervention
- heart failure
- left ventricular
- st elevation myocardial infarction
- clinical trial
- coronary artery disease
- acute coronary syndrome
- pulmonary hypertension
- acute heart failure
- atrial fibrillation
- mitral valve
- left atrial
- cardiac resynchronization therapy